• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR Back to Search Results
Model Number CNWTT0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Diplopia/Double Vision (4802)
Date of Event 04/08/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A health care professional reported with a description of, lens was successfully implanted in both eyes of a patient with epiretinal membrane (erm) disease in only one eye.The eye which had cataract only has no problem on visibility, however the patient had double vision on the other eye of erm although the intraocular lens (iol) of the same model were implanted in both eyes of the patient.Therefore the operation of replacement with another lens model was performed.After the replacement the patient can see without any issue.
 
Additional Manufacturer Narrative
Additional information was provided in h.3., h.6 and h.11.The product was not returned for analysis.As per the dr.'s opinion, although the reason why the event occurred was unknown, it was not due to iol (intra ocular lens) itself.He/she was relieved the situation was resolved without any problems as a result.The root cause for the reported complaint appears to be a coincidental event that was unrelated to the product as user facility reported that according to the surgeon, the iol did not cause the event.Based on this information, the product did not cause/contribute to the event.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS
Common Device Name
LENS, MULTIFOCAL INTRAOCULAR
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key19400443
Report Number9612169-2024-00489
Device Sequence Number15510703
Product Code MFK
UDI-Device Identifier00380652407984
UDI-Public(01)00380652407984(17)260419(11)220421(10)25398769(21)25398769186
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/19/2026
Device Model NumberCNWTT0
Device Catalogue NumberCNWTT0.130
Device Lot Number25398769
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/30/2024
Supplement Date Received by Manufacturer07/26/2024
Initial Report FDA Received Date05/27/2024
Supplement Report FDA Received Date08/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/21/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AE-9063CSP - INJECTOR; CLAREON VIVITY UV ABSORBING IOL; MONARCH III CARTRIDGE D
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-